TrialDiabetologia2012

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience.

D E Bonds et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.